Skip to content

Development and Application of a Medication Literacy Assessment Scale for Patients with Mental Disorders in Recovery

Development and Application of a Medication Literacy Assessment Scale for Patients with Mental Disorders in Recovery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091901
Enrollment
Unknown
Registered
2024-11-05
Start date
2024-11-05
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Interventions

Observation group:None

Sponsors

Huzhou University,Huzhou Third Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years; meeting the diagnostic criteria for schizophrenia, schizoaffective disorder, paranoid psychosis, epilepsy-induced psychotic disorder, depressive disorder, bipolar disorder, and anxiety disorder in The International Statistical Classification of Diseases and Related Health Problems 10th Revision; (2) Diagnosed by the doctor, the patient after the acute and consolidation treatment stages, Positive and Negative Symptom Scale, PANSS total score reduction rate = 50% or PANSS total score = 60, hallucinations, delusions and other psychiatric symptoms are controlled, the condition is stabilized, the mood improves, the behavior is normal; (3) No visual or hearing impairment; clear consciousness, able to understand the content and clear expression of language; (4) Patients volunteered to participate in this study and signed an informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: (1) Those who are currently or have been diagnosed with delirium, dementia, mental retardation with mental disorder; (2) Those with mental disorder due to physical illness or mental disorder due to psychoactive substances; (3) Those with severe physical illness and unstable condition; (4) Those who are currently or have been suffering from traumatic brain injury or other known organic diseases of the central nervous system; (5) Those who are at a higher risk of suicide or violence in the course of the study; and (6) Those who have participated in the study within 12 months or are participating in a study related to medication management, medication skills training, etc.

Design outcomes

Primary

MeasureTime frame
Reliability and validity;demographic factors;Morisky Medication Adherence Scale,MMAS-8;Self-efficacy for Appropriate Medication Use Scale, SEAMS;General Self Efficacy Scale,GSES;insight and treatment attitudes questionnaire,ITAQ;perceived social support scale, PSSS;family concern index questionnaire,APGAR;

Countries

China

Contacts

Public ContactDeng Lin

Huzhou University,Huzhou Third Municipal Hospital

906208943@qq.com+86 185 1570 8803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026